Table 1.
Characteristics | No. Subjects (%) |
---|---|
Age, median [IQR], yrs | 48 [44–53] |
Gender (M/F) | 161/63 |
Race | |
Blacks | 201 (90) |
Whites | 22 (10) |
Hispanic or Latino | 1 (0.5) |
Smoking Status | |
Former | 25 (11) |
Current | 199 (89) |
Never | 0 (0) |
Pack-years smoked, median [IQR], yrs | 34 [31–36] |
History of Marijuana Use | 90 (40) |
History of Cocaine Use | 65 (29) |
IVDUb | 129 (58) |
Hepatitis Cc | 114 (54) |
TB skin test positived | 44 (21) |
STDe | 84(44) |
AZTf | 143 (68) |
CD4 nadir, median [IQR], cells/mm3 g | 179 [61–332] |
CD4 cell count, median [IQR], cells/mm3 h | 400 [217–568] |
Viral load <400 cells/mm3 i | 123 (59.1) |
FEV1, median [IQR],% Predicted | 85 [70–101] |
FVC, median [IQR], % Predicted | 88 [74–101] |
FEV1/FVC, median [IQR], | 81 [73–91] |
Highest Educational Level Attainedj | |
Middle school | 65 (52) |
High School | 40 (32) |
College Degree | 21 (17) |
Annual Incomek | |
<$ 8,000 | 63 (72) |
$ 8,000 to $14,999 | 12 (14) |
$ 15,000 to $24,999 | 10 (12) |
$ 25,000 to $49,999 | 2 (3) |
Abbreviations: IQR, Interquartile Range; IVDU, Intravenous Venous Drug User; TB, Tuberculosis; STD, Sexually Transmitted Disease; AZT, Azidothymidine.
Some subjects had missing demographic data as noted.
n = 222,
n = 213,
n = 210,
n = 189,
n = 209,
n = 200,
n = 187,
n = 207,
n = 126,
n = 87